1st June 2021
Filter by
Dates
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2020
- June 2020
- April 2020
- March 2020
- January 2020
- December 2019
- November 2019
- September 2019
- February 2019
- January 2019
- September 2018
- August 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- September 2017
- June 2017
- April 2017
- January 2017
- August 2016
Latest news
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
5th May 2021
RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®
4th May 2021
Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
28th April 2021
Curium to Expand Noblesville Facility’s Workforce
23rd March 2021
RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)
17th March 2021
A statement on the use of Xenon Xe 133 Gas during the COVID-19 pandemic
2nd March 2021
Eckert & Ziegler’s GalliaPharm® distributed by Curium in France
2nd February 2021
Curium is attending these global congresses in 2021
26th January 2021
RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)
9th December 2020
RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)
8th September 2020
RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.
9th June 2020
Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe
16th April 2020
A message from Curium on COVID-19 and our actions
24th March 2020
Curium Announces Approval of PulmotechTM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration
12th March 2020
RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA
3rd March 2020
Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio
30th January 2020
Curium is attending these global congresses in 2020
7th January 2020
RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application
2nd December 2019
Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy
16th November 2019